Human Molecular GeneticsNeurosciencePeer-reviewed journal article
Distinct roles for the Charcot-Marie-Tooth disease-causing endosomal regulators Mtmr5 and Mtmr13 in axon radial sorting and Schwann cell myelination
Anna MammeliD, Katherine C. Delgado, Andrea L. ChiniD, Alec F. CondoniD, Jo Q. HilliD, Sue A. AicheriD, Yingming WangiD, Lev M. FedoroviD, Fred L. RobinsoniD
Abstract
The form of Charcot-Marie-Tooth type 4B (CMT4B) disease caused by mutations in myotubularin-related 5 (MTMR5; also called SET Binding Factor 1; SBF1) shows a spectrum of axonal and demyelinating nerve phenotypes. This contrasts with the CMT4B subtypes caused by MTMR2 or MTMR13 (SBF2) mutations, which are characterized by myelin outfoldings and classic demyelination. Thus, it is unclear whether MTMR5 plays an analogous or distinct role from that of its homolog, MTMR13, in the peripheral nervous system (PNS). MTMR5 and MTMR13 are pseudophosphatases predicted to regulate endosomal trafficking by activating Rab GTPases and binding to the phosphoinositide 3-phosphatase MTMR2. In the mouse PNS, Mtmr2 was required to maintain wild type levels of Mtmr5 and Mtmr13, suggesting that these factors function in discrete protein complexes. Genetic elimination of both Mtmr5 and Mtmr13 in mice led to perinatal lethality, indicating that the two proteins have partially redundant functions during embryogenesis. Loss of Mtmr5 in mice did not cause CMT4B-like myelin outfoldings. However, adult Mtmr5-/- mouse nerves contained fewer myelinated axons than control nerves, likely as a result of axon radial sorting defects. Mtmr5 levels were highest during axon radial sorting, whereas Mtmr13 levels rose as myelin formed, and remained high through adulthood. Our findings suggest that Mtmr5 and Mtmr13 ensure proper axon radial sorting and Schwann cell myelination, respectively, perhaps through their direct interactions with Mtmr2. This study enhances our understanding of the non-redundant roles of the endosomal regulators MTMR5 and MTMR13 during normal peripheral nerve development and disease.
- Citations
- 18
- FWCI
- 1.38
- Field percentile
- top 21%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Imbalance of Neuregulin1-ErbB2/3 signaling underlies altered myelin homeostasis in models of Charcot-Marie-Tooth disease type 4H
Lara El-Bazzal, Adeline Spiga Ghata, … Nathalie Bernard‐Marissal·bioRxiv·Jan 20, 2022
- Defining and rescuing pathomechanisms of myotubularin and autophagy disruption in a novel human cell model of Charcot-Marie-Tooth Type 4B3
Malika Sharma, Xinyi S Mao, … Jason P. Chua·bioRxiv·Feb 5, 2026
- Enhanced axonal Neuregulin-1 type-III signaling ameliorates disease severity in a CMT1B mouse model
Cristina Scapin, Cinzia Ferri, … Maurizio D’Antonio·bioRxiv·Aug 7, 2018
- Characterization of a novel zebrafish model of MTMR5-associated CMT4B3
Jordan Lindzon, Maia List, … James J. Dowling·bioRxiv·Apr 18, 2024
- Progressive axonopathy when oligodendrocytes lack the myelin protein CMTM5
Tobias J. Buscham, Maria A. Eichel‐Vogel, … Hauke B. Werner·eLifePeer-reviewed·Feb 28, 2022
- Activation of XBP1s attenuates disease severity in models of proteotoxic Charcot-Marie-Tooth type 1B
Thierry Touvier, Francesca A Veneri, … Maurizio D’Antonio·BrainPeer-reviewed·Dec 20, 2024